Bcl-2 overexpression is commonly associated with various cancers including breast cancer, prostate cancer, B-cell lymphomas and colorectal adenocarcinomas, etc. Thus, Bcl-2 is a novel anti-cancer target attracting medicinal chemists across the globe [27]. This evidence concerns the gene BCL2 and B-cell non-Hodgkin lymphoma.